An exploratory phase IIIb, single-blind, outpatient study to assess next-day functioning in adult primary insomnia patients following the administration of NBI-34060 [indiplon] capsules during the night

Trial Profile

An exploratory phase IIIb, single-blind, outpatient study to assess next-day functioning in adult primary insomnia patients following the administration of NBI-34060 [indiplon] capsules during the night

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 14 May 2015

At a glance

  • Drugs Indiplon (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Sponsors Neurocrine Biosciences
  • Most Recent Events

    • 11 May 2015 Status changed from discontinued to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
    • 23 Jan 2008 updated status and actual end date according to nct dated 14 jan 08.
    • 14 Jan 2008 Status changed from recruiting to discontinued.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top